AbbVie unveils Venclexta data that scored lightning-fast leukemia combination nod
Last month, partners AbbVie and Roche nabbed a speedy approval for Venclexta and Gazyva in chronic lymphocytic leukemia. And Tuesday, they rolled out the data that helped push them across the finish line.
Source: Fierce Pharma
AbbVie unveils Venclexta data that scored lightning-fast leukemia combination nod
